» Articles » PMID: 32459063

VX-765 Enhances Autophagy of Human Umbilical Cord Mesenchymal Stem Cells Against Stroke-induced Apoptosis and Inflammatory Responses Via AMPK/mTOR Signaling Pathway

Overview
Specialties Neurology
Pharmacology
Date 2020 May 28
PMID 32459063
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: To investigate the protective effect of VX-765 on human umbilical mesenchymal stem cells (HUMSCs) in stroke and its mechanism.

Materials And Methods: Mouse models of ischemic stroke were established using the distal middle cerebral artery occlusion (dMCAO) method. The dMCAO mice were accordingly transplanted with HUMSCs, VX-765-treated HUMSCs, or VX-765 + MHY185-treated HUMSCs. The HUMSCs were inserted with green fluorescent protein (GFP) for measurement of transplantation efficiency which was determined by immunofluorescence assay. Oxygen-glucose deprivation (OGD) was applied to mimic ischemic environment in vitro experiments, and the HUMSCs herein were transfected with AMPK inhibitor Compound C or autophagy inhibitor 3-MA. MTT assay was used to test the toxicity of VX-765. TUNEL staining and ELISA were applied to measure the levels of apoptosis and inflammatory cytokines (IL-1β, IL-6, and IL-10), respectively. The expressions of autophagy-associated proteins, AMPK, and mTOR were detected by Western blotting. TTC staining was applied to reveal the infarct lesions in the brain of dMCAO mice.

Results: The pro-inflammatory cytokines, TUNEL-positive cells, and p-mTOR were decreased while the anti-inflammatory cytokine, autophagy-related proteins, and p-AMPK were increased in HUMSCs treated with VX-765 under OGD condition. Different expression patterns were found with the above factors after transfection of 3-MA or Compound C. The pro-inflammatory cytokines, TUNEL-positive cells, and infarct sections were decreased while the anti-inflammatory cytokine and autophagy-related proteins were increased in dMCAO mice transplanted with VX-765-treated HUMSCs compared to those transplanted with HUMSCs only. The autophagy was inhibited while p-mTOR was up-regulated after transfection of MHY.

Conclusion: VX-765 protects HUMSCs against stroke-induced apoptosis and inflammatory responses by activating autophagy via the AMPK/mTOR signaling pathway in vivo and in vitro.

Citing Articles

Research progress and challenges of stem cell therapy for ischemic stroke.

Cha Z, Qiao Y, Lu Q, Wang Q, Lu X, Zhou H Front Cell Dev Biol. 2024; 12:1410732.

PMID: 39040041 PMC: 11260720. DOI: 10.3389/fcell.2024.1410732.


Lycium barbarum polysaccharide inhibits ischemia-induced autophagy by promoting the biogenesis of neural stem cells-derived extracellular vesicles to enhance the delivery of miR-133a-3p.

Li R, Duan W, Feng T, Gu C, Zhang Q, Long J Chin Med. 2023; 18(1):117.

PMID: 37691119 PMC: 10494430. DOI: 10.1186/s13020-023-00831-8.


Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation.

Lockard G, Alayli A, Monsour M, Gordon J, Schimmel S, Elsayed B Int J Mol Sci. 2022; 23(24).

PMID: 36555094 PMC: 9779061. DOI: 10.3390/ijms232415453.


Contemplating IL-6, a double-edged sword cytokine: Which side to use for stroke pathology?.

Monsour M, Croci D, Agazzi S, Borlongan C CNS Neurosci Ther. 2022; 29(2):493-497.

PMID: 36478506 PMC: 9873516. DOI: 10.1111/cns.14041.


Lipopolysaccharide Promotes the Proliferation and Differentiation of Goose Embryonic Myoblasts by Promoting Cytokine Expression and Appropriate Apoptosis Processes.

Wang J, Fu M, Xu D, Cao N, Li W, Tian Y Vet Sci. 2022; 9(11).

PMID: 36356092 PMC: 9692480. DOI: 10.3390/vetsci9110615.


References
1.
Bang O, Kim E, Cha J, Moon G . Adult Stem Cell Therapy for Stroke: Challenges and Progress. J Stroke. 2016; 18(3):256-266. PMC: 5066440. DOI: 10.5853/jos.2016.01263. View

2.
Bernstock J, Peruzzotti-Jametti L, Ye D, Gessler F, Maric D, Vicario N . Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering. J Cereb Blood Flow Metab. 2017; 37(7):2314-2319. PMC: 5531358. DOI: 10.1177/0271678X17700432. View

3.
Goyal M, Demchuk A, Menon B, Eesa M, Rempel J, Thornton J . Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372(11):1019-30. DOI: 10.1056/NEJMoa1414905. View

4.
Broughton B, Lim R, Arumugam T, Drummond G, Wallace E, Sobey C . Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells. Front Cell Neurosci. 2013; 6:66. PMC: 3547279. DOI: 10.3389/fncel.2012.00066. View

5.
Zhang Y, Zheng Y . Effects and mechanisms of potent caspase-1 inhibitor VX765 treatment on collagen-induced arthritis in mice. Clin Exp Rheumatol. 2016; 34(1):111-8. View